A randomised, double-blind, placebo controlled, cross-over trial of adjunctive L-arginine in schizophrenia

被引：0
|
作者：
Kocyigit, Y. [1 ]
Ayhan, Y. [1 ]
Yoca, G. [1 ]
Karahan, S. [2 ]
Yazici, M. K. [1 ]
机构：
[1] Hacettepe Univ, Fac Med, Dept Psychiat, TR-06100 Ankara, Turkey
[2] Hacettepe Univ, Fac Med, Dept Biostat, TR-06100 Ankara, Turkey
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2013年 / 23卷
关键词：
D O I：
10.1016/S0924-977X(13)70767-3
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.d.044
引用
收藏
页码：S484 / S484
页数：1
相关论文
共 50 条
  • [21] Nicotine and Behavioral Markers of Risk for Schizophrenia: A Double-Blind, Placebo-Controlled, Cross-Over Study
    Lana Dépatie
    Gillian A O′Driscoll
    Anne-Lise V Holahan
    Victoria Atkinson
    Joseph X Thavundayil
    N Ng Ying Kin
    Samarthji Lal
    [J]. Neuropsychopharmacology, 2002, 27 : 1056 - 1070
  • [22] L-Arginine Add-On Treatment for Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
    Kocyigit, Yasemin
    Yoca, Gokhan
    Karahan, Sevilay
    Ayhan, Yavuz
    Yazici, Mumin Kazim
    [J]. TURK PSIKIYATRI DERGISI, 2018, 29 (03) : 147 - 153
  • [23] A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
    Akihiro Shiina
    Yukihiko Shirayama
    Tomihisa Niitsu
    Tasuku Hashimoto
    Taisuke Yoshida
    Tadashi Hasegawa
    Tadashi Haraguchi
    Nobuhisa Kanahara
    Tetsuya Shiraishi
    Mihisa Fujisaki
    Goro Fukami
    Michiko Nakazato
    Masaomi Iyo
    Kenji Hashimoto
    [J]. Annals of General Psychiatry, 9
  • [24] Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial
    Akhondzadeh, Shahin
    Tabatabaee, Maryam
    Amini, Homayoun
    Abhari, Seyed Ali Ahmadi
    Abbasi, Seyed Hesamedin
    Behnam, Behnaz
    [J]. SCHIZOPHRENIA RESEARCH, 2007, 90 (1-3) : 179 - 185
  • [25] A double-blind placebo-controlled cross over trial of bupropion in smoking reduction in schizophrenia
    Fatemi, SH
    Stary, JM
    Hatsukami, DK
    Murphy, SE
    [J]. SCHIZOPHRENIA RESEARCH, 2005, 76 (2-3) : 353 - 356
  • [26] High dose gabapentin for essential tremor: A double-blind, placebo-controlled, cross-over trial
    Jankovic, JJ
    Hunter, C
    Schwartz, K
    Ondo, WG
    [J]. NEUROLOGY, 1999, 52 (06) : A456 - A456
  • [27] LAMOTRIGINE THERAPY FOR PARTIAL SEIZURES - A MULTICENTER, PLACEBO-CONTROLLED, DOUBLE-BLIND, CROSS-OVER TRIAL
    MESSENHEIMER, J
    RAMSAY, RE
    WILLMORE, LJ
    LEROY, RF
    ZIELINSKI, JJ
    MATTSON, R
    PELLOCK, JM
    VALAKAS, AM
    WOMBLE, G
    RISNER, M
    [J]. EPILEPSIA, 1994, 35 (01) : 113 - 121
  • [28] DIPYRIDAMOLE FOR THE TREATMENT OF RLS: PRELIMINARY RESULTS OF A CROSS-OVER, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL
    Garcia-Borreguero, D.
    Granizo, J.
    Ferre, S.
    [J]. SLEEP, 2020, 43 : A303 - A303
  • [29] AMLODIPINE IN PATIENTS WITH ANGINA UNCONTROLLED BY ATENOLOL - A DOUBLE-BLIND PLACEBO-CONTROLLED CROSS-OVER TRIAL
    WOODMANSEY, PA
    STEWART, AG
    MORICE, AH
    CHANNER, KS
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 45 (02) : 107 - 111
  • [30] Improvement of Seminal Parameters with Prelox®: A Randomized, Double-blind, Placebo-controlled, Cross-over Trial
    Stanislavov, R.
    Nikolova, V.
    Rohdewald, P.
    [J]. PHYTOTHERAPY RESEARCH, 2009, 23 (03) : 297 - 302
12345